股本结构

单位:万股
公告日期 2025-04-22 2025-03-07 2025-03-07 2024-11-04 2024-08-06 2024-05-14
证券总股本 1721.22 1686.76 1686.52 1685.04 1684.76 1678.96
普通股本 1721.22 1686.76 1686.52 1685.04 1684.76 1678.96
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-03-31 2025-03-06 2024-12-31 2024-09-30 2024-06-30 2024-05-10
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2025-04-22 1721.22 未披露
更多>>
From December 31, 2024 to March 31, 2025 Vesting of restricted stock units
2025-03-31
2025-03-07 1686.76 未披露 定期报告 2025-03-06
2025-03-07 1686.52 未披露
更多>>
From December 31, 2023 to December 31, 2024 Repurchase of early exercised shares Issuance of common stock under 2018 ESPP Vesting of restricted stock units
2024-12-31
2024-11-04 1685.04 未披露
更多>>
From June 30, 2024 to September 30, 2024 Vesting of restricted stock units
2024-09-30
2024-08-06 1684.76 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common stock under 2018 ESPP Vesting of restricted stock units
2024-06-30
2024-05-14 1678.96 未披露 定期报告 2024-05-10
2024-05-14 1678.66 未披露
更多>>
From December 31, 2023 to March 31, 2024 Repurchase of early exercised shares Vesting of restricted stock units
2024-03-31
2024-04-15 1678.50 未披露
更多>>
From December 31, 2022 to December 31, 2023 Issuance of common stock under the warrant inducement agreement, net of issuance costs Issuance of common stock, net of issuance costs, under ATM equity offering program Issuance of common stock under 2018 ESPP Vesting of restricted stock units
2023-12-31
2023-12-06 1678.50 未披露 定期报告 2023-12-05
2023-11-13 1462.07 未披露 定期报告 2023-11-08
2023-11-13 1461.49 未披露
更多>>
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units
2023-09-30
2023-08-08 1460.13 未披露 定期报告 2023-08-04
2023-08-08 1459.55 未披露
更多>>
From March 31, 2023 to June 30, 2023 Issuance of common stock, net of issuance costs, under at-the-market (“ATM”) offering program Issuance of common stock under 2018 ESPP Vesting of restricted stock units
2023-06-30
2023-05-09 1436.50 未披露 定期报告 2023-05-05
2023-05-09 1435.92 未披露
更多>>
From December 31, 2022 to March 31, 2023 Issuance of common stock, net of issuance costs, under at-the-market (“ATM”) offering program Vesting of restricted stock units
2023-03-31
2023-03-15 1433.91 未披露 定期报告 2023-03-10
2023-03-15 1421.53 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs, under ATM equity offering program Sale of common stock and warrants to purchase common shares under follow-on offering, net of issuance costs Issuance of common stock to Lincoln Park Capital Fund,net of issuance costs Issuance of common stock Hercules Capital,net of issuance costs Issuance of common stock under 2018 ESPP Vesting of restricted stock units
2022-12-31
2022-11-08 1419.23 未披露 定期报告 2022-11-04
2022-10-19 1403.63 未披露
更多>>
UNITY Biotechnology, Inc. announced that its Board of Directors has approved a 1-for-10 reverse stock split of UNITY’s common stock.
2022-10-20
2022-11-08 14036.25 未披露
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common stock, net of issuance costs, under ATM equity offering program Sale of common stock and warrants to purchase common shares under follow-on offering, net of issuance costs Vesting of restricted stock units
2022-09-30
2022-09-13 14022.61 未披露 定期报告 2022-08-29
2022-08-22 13387.06 未披露
更多>>
1.Common stock offered by 64,285,714 shares of common stock 2.The number of shares of common stock to be outstanding immediately after this offering is based on 69,584,933 shares of common stock outstanding as of June 30, 2022
2022-08-22
2022-08-12 6965.10 未披露 定期报告 2022-08-11
2022-08-12 6958.49 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock under 2018 ESPP Vesting of restricted stock units
2022-06-30
2022-05-10 6916.89 未披露 定期报告 2022-05-05
2022-05-10 6914.81 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock, net of issuance costs, under ATM offering program Issuance of common stock to Lincoln Park Capital Fund Issuance of common stock to Hercules Capital Vesting of restricted stock units
2022-03-31
2022-03-15 6892.79 未披露 定期报告 2022-03-10
2022-03-15 6299.19 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs, under ATM equity offering program Issuance of common stock to Lincoln Park Capital Fund, net of issuance costs Issuance of common stock upon exercise of stock options Issuance of common stock under 2018 ESPP Common stock granted to third party Repurchase of early exercised shares Vesting of restricted stock units
2021-12-31
2021-11-10 5772.42 未披露 定期报告 2021-11-05
2021-11-10 5746.99 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock to Lincoln Park Capital Fund, net of issuance costs Common stock granted to third party Vesting of restricted stock units
2021-09-30
2021-08-10 5510.43 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock upon exercise of stock options Issuance of common stock under 2018 ESPP Vesting of restricted stock units
2021-06-30
2021-05-11 5485.52 未披露 定期报告 2021-05-07
2021-05-11 5478.77 未披露
更多>>
From December 31, 2020 To March 31, 2021 Issuance of common stock, net of issuance costs, under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Repurchase of early exercised shares Vesting of restricted stock units
2021-03-31
2021-03-23 5469.95 未披露 定期报告 2021-03-19
2021-03-23 5325.32 未披露
更多>>
from December 31, 2019 to December 31, 2020 Issuance of common stock, net of issuance costs, under ATM equity offering program Issuance of common stock upon exercise of stock options Issuance of common stock upon vesting of restricted stock units Common stock issued for services Common stock issued to third parties for milestone payments Repayment of promissory note from employee through repurchase of early exercise shares Issuance of common stock under 2018 ESPP
2020-12-31
2020-11-04 5291.32 未披露 定期报告 2020-10-30
2020-11-04 5288.32 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock, net of issuance costs,under ATM equity offering program Issuance of common stock upon exercise of stock options Issuance of common stock in settlement of contingent consideration milestone Repayment of promissory note from employee through repurchase of early exercise shares
2020-09-30
2020-07-31 5204.00 未披露 定期报告 2020-07-27
2020-07-31 5172.95 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock, net of issuance costs,under ATM equity offering program Issuance of common stock upon exercise of stock options Issuance of common stock from restricted stock units Issuance of common stock under employee stock purchase plan ("2018 ESPP")
2020-06-30
2020-05-07 4914.31 未披露 定期报告 2020-05-04
2020-04-24 4902.53 未披露 定期报告 2020-04-20
2020-05-07 4885.75 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issuance of common stock, net of issuance costs,under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Common stock issued for services
2020-03-31
2020-03-11 4761.31 未披露 定期报告 2020-03-06
2020-03-11 4722.71 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of common stock, net of issuance costs, under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Common stock issued to third parties Repurchased shares Issuance of common stock under employee stock purchase plan (“ESPP”)
2019-12-31
2019-11-06 4594.18 未披露 定期报告 2019-11-01
2019-11-06 4408.83 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common stock, net of issuance costs, under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Repurchased shares
2019-09-30
2019-08-07 4320.31 未披露 定期报告 2019-08-01
2019-08-07 4320.36 未披露
更多>>
from March 31, 2019 to June 30,2019 Issuance of common stock upon exercise of stock options Common stock issued to third party for a license Repurchased shares Issuance of common stock under employee stock purchase plan (“ESPP”)
2019-06-30
2019-06-07 5194.63 未披露 定期报告 2019-06-07
2019-04-26 4290.71 未披露 定期报告 2019-04-22
2019-05-08 4288.84 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock upon exercise of stock options Common stock issued to third parties
2019-03-31
2019-03-06 4285.70 未披露 定期报告 2019-03-01
2019-03-06 4241.43 未披露
更多>>
From December 31, 2017 to December 31, 2018 Issuance of Series C convertible preferred stock at $15.3317 per share for cash, net of issuance costs of $119 Issuance of common stock upon initial public offering, net of issuance costs of $9,149 Conversion of Series A-1, A-2, B and C convertible preferred stock to common stock Issuance of common stock upon exercise of warrants and stock options,net of amount related to early exercised options of $1,212
2018-12-31
2018-11-07 4232.26 未披露 定期报告 2018-10-31
2018-11-07 4231.76 未披露 定期报告 2018-09-30
2018-08-09 4231.47 未披露 定期报告 2018-06-30
2018-06-07 4231.36 未披露 定期报告 2018-05-31
2018-05-04 4190.35 未披露
更多>>
1.Common stock offered 5,000,000 shares 2.The number of shares of common stock to be outstanding after this offering is based on 4,830,389 shares of common stock outstanding as of December 31, 2017 3.a 1-for-2.95 reverse stock split of our capital stock, which we effected on April 20, 2018
2018-05-03
2018-06-07 523.10 3175.03 定期报告 2018-03-31
2018-04-23 483.04 2815.97
更多>>
from December 31, 2016 to December 31, 2017 Issuance of Series B convertible preferred stock at $4.11 per share for cash, net of issuance costs of $43 Issuance of common stock upon exercise of stock options, net of amount related to early exercised options of $5 Issuance of restricted stock Common stock granted to third party Repurchase of early exercised shares of common stock A 1-for-2.95 reverse stock split of our capital stock, which we effected on April 20, 2018
2017-12-31
From December 31, 2024 to March 31, 2025 Vesting of restricted stock units
From December 31, 2023 to December 31, 2024 Repurchase of early exercised shares Issuance of common stock under 2018 ESPP Vesting of restricted stock units
From June 30, 2024 to September 30, 2024 Vesting of restricted stock units
From March 31, 2024 to June 30, 2024 Issuance of common stock under 2018 ESPP Vesting of restricted stock units
From December 31, 2023 to March 31, 2024 Repurchase of early exercised shares Vesting of restricted stock units
From December 31, 2022 to December 31, 2023 Issuance of common stock under the warrant inducement agreement, net of issuance costs Issuance of common stock, net of issuance costs, under ATM equity offering program Issuance of common stock under 2018 ESPP Vesting of restricted stock units
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units
From March 31, 2023 to June 30, 2023 Issuance of common stock, net of issuance costs, under at-the-market (“ATM”) offering program Issuance of common stock under 2018 ESPP Vesting of restricted stock units
From December 31, 2022 to March 31, 2023 Issuance of common stock, net of issuance costs, under at-the-market (“ATM”) offering program Vesting of restricted stock units
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs, under ATM equity offering program Sale of common stock and warrants to purchase common shares under follow-on offering, net of issuance costs Issuance of common stock to Lincoln Park Capital Fund,net of issuance costs Issuance of common stock Hercules Capital,net of issuance costs Issuance of common stock under 2018 ESPP Vesting of restricted stock units
UNITY Biotechnology, Inc. announced that its Board of Directors has approved a 1-for-10 reverse stock split of UNITY’s common stock.
From June 30, 2022 to September 30, 2022 Issuance of common stock, net of issuance costs, under ATM equity offering program Sale of common stock and warrants to purchase common shares under follow-on offering, net of issuance costs Vesting of restricted stock units
1.Common stock offered by 64,285,714 shares of common stock 2.The number of shares of common stock to be outstanding immediately after this offering is based on 69,584,933 shares of common stock outstanding as of June 30, 2022
From March 31, 2022 to June 30, 2022 Issuance of common stock under 2018 ESPP Vesting of restricted stock units
From December 31, 2021 to March 31, 2022 Issuance of common stock, net of issuance costs, under ATM offering program Issuance of common stock to Lincoln Park Capital Fund Issuance of common stock to Hercules Capital Vesting of restricted stock units
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs, under ATM equity offering program Issuance of common stock to Lincoln Park Capital Fund, net of issuance costs Issuance of common stock upon exercise of stock options Issuance of common stock under 2018 ESPP Common stock granted to third party Repurchase of early exercised shares Vesting of restricted stock units
From June 30, 2021 to September 30, 2021 Issuance of common stock to Lincoln Park Capital Fund, net of issuance costs Common stock granted to third party Vesting of restricted stock units
From March 31, 2021 to June 30, 2021 Issuance of common stock upon exercise of stock options Issuance of common stock under 2018 ESPP Vesting of restricted stock units
From December 31, 2020 To March 31, 2021 Issuance of common stock, net of issuance costs, under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Repurchase of early exercised shares Vesting of restricted stock units
from December 31, 2019 to December 31, 2020 Issuance of common stock, net of issuance costs, under ATM equity offering program Issuance of common stock upon exercise of stock options Issuance of common stock upon vesting of restricted stock units Common stock issued for services Common stock issued to third parties for milestone payments Repayment of promissory note from employee through repurchase of early exercise shares Issuance of common stock under 2018 ESPP
From June 30, 2020 to September 30, 2020 Issuance of common stock, net of issuance costs,under ATM equity offering program Issuance of common stock upon exercise of stock options Issuance of common stock in settlement of contingent consideration milestone Repayment of promissory note from employee through repurchase of early exercise shares
From March 31, 2020 to June 30, 2020 Issuance of common stock, net of issuance costs,under ATM equity offering program Issuance of common stock upon exercise of stock options Issuance of common stock from restricted stock units Issuance of common stock under employee stock purchase plan ("2018 ESPP")
From December 31, 2019 to March 31, 2020 Issuance of common stock, net of issuance costs,under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Common stock issued for services
from December 31, 2018 to December 31, 2019 Issuance of common stock, net of issuance costs, under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Common stock issued to third parties Repurchased shares Issuance of common stock under employee stock purchase plan (“ESPP”)
from June 30, 2019 to September 30, 2019 Issuance of common stock, net of issuance costs, under at-the-market ("ATM") equity offering program Issuance of common stock upon exercise of stock options Repurchased shares
from March 31, 2019 to June 30,2019 Issuance of common stock upon exercise of stock options Common stock issued to third party for a license Repurchased shares Issuance of common stock under employee stock purchase plan (“ESPP”)
from December 31, 2018 to March 31, 2019 Issuance of common stock upon exercise of stock options Common stock issued to third parties
From December 31, 2017 to December 31, 2018 Issuance of Series C convertible preferred stock at $15.3317 per share for cash, net of issuance costs of $119 Issuance of common stock upon initial public offering, net of issuance costs of $9,149 Conversion of Series A-1, A-2, B and C convertible preferred stock to common stock Issuance of common stock upon exercise of warrants and stock options,net of amount related to early exercised options of $1,212
1.Common stock offered 5,000,000 shares 2.The number of shares of common stock to be outstanding after this offering is based on 4,830,389 shares of common stock outstanding as of December 31, 2017 3.a 1-for-2.95 reverse stock split of our capital stock, which we effected on April 20, 2018
from December 31, 2016 to December 31, 2017 Issuance of Series B convertible preferred stock at $4.11 per share for cash, net of issuance costs of $43 Issuance of common stock upon exercise of stock options, net of amount related to early exercised options of $5 Issuance of restricted stock Common stock granted to third party Repurchase of early exercised shares of common stock A 1-for-2.95 reverse stock split of our capital stock, which we effected on April 20, 2018